These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 24235225)

  • 1. Pharmacokinetic/pharmacodynamic evaluation of the efficacy of flumequine in treating colibacillosis in turkeys.
    Ferraresi C; Lucatello L; Meucci V; Intorre L; Grilli G; Piccirillo A; Russo E; Villa R; Montesissa C; Cagnardi P
    Poult Sci; 2013 Dec; 92(12):3158-65. PubMed ID: 24235225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enrofloxacin against Escherichia coli in turkeys: which treatment scheme is effective?
    Cagnardi P; Ferraresi C; Lucatello L; Meucci V; Intorre L; Grilli G; Piccirillo A; Giacomelli M; Montesissa C
    Poult Sci; 2014 Jul; 93(7):1667-74. PubMed ID: 24864295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Approved medication of water with enrofloxacin to treat turkey colibacillosis: assessment of efficacy using a PK/PD approach.
    Russo E; Lucatello L; Giovanardi D; Cagnardi P; Ortali G; Di Leva V; Montesissa C
    Vet Microbiol; 2012 Dec; 161(1-2):206-12. PubMed ID: 22884281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic-pharmacodynamic modelling of danofloxacin in turkeys.
    Haritova AM; Rusenova NV; Parvanov PR; Lashev LD; Fink-Gremmels J
    Vet Res Commun; 2006 Oct; 30(7):775-89. PubMed ID: 17004040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integration of pharmacokinetic and pharmacodynamic indices of marbofloxacin in turkeys.
    Haritova AM; Rusenova NV; Parvanov PR; Lashev LD; Fink-Gremmels J
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3779-85. PubMed ID: 16940071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of in vitro activities and pharmacokinetics/pharmacodynamics estimations of veterinary fluoroquinolones against avian pathogenic Escherichia coli isolates.
    Ozawa M; Baba K; Shimizu Y; Asai T
    Microb Drug Resist; 2010 Dec; 16(4):327-32. PubMed ID: 20624095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and pharmacodynamics of enrofloxacin treatment of Escherichia coli in a murine thigh infection modeling.
    Liu X; Yang Q; Fan Y; Du Y; Lei L; Wang D; Liu Y
    BMC Vet Res; 2021 Jun; 17(1):212. PubMed ID: 34107961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic and pharmacodynamic properties of gamithromycin in turkey poults with respect to Ornithobacterium rhinotracheale.
    Watteyn A; Devreese M; De Baere S; Wyns H; Plessers E; Boyen F; Haesebrouck F; De Backer P; Croubels S
    Poult Sci; 2015 Sep; 94(9):2066-74. PubMed ID: 26195808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic-pharmacodynamic relationship of marbofloxacin for Escherichia coli and Pasturella multocida following repeated intramuscular administration in goats.
    Bhardwaj P; Sidhu PK; Saini SPS; M B D; Rampal S
    J Vet Pharmacol Ther; 2019 Jul; 42(4):430-439. PubMed ID: 31102281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistant cutoff values and optimal scheme establishments for florfenicol against Escherichia coli with PK-PD modeling analysis in pigs.
    Lei Z; Liu Q; Khaliq H; Cao J; He Q
    J Vet Pharmacol Ther; 2019 May; 42(3):324-335. PubMed ID: 30801741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro Dynamic Pharmacokinetic/Pharmacodynamic (PK/PD) study and COPD of Marbofloxacin against Haemophilus parasuis.
    Sun J; Xiao X; Huang RJ; Yang T; Chen Y; Fang X; Huang T; Zhou YF; Liu YH
    BMC Vet Res; 2015 Dec; 11():293. PubMed ID: 26626889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ex vivo pharmacokinetic and pharmacodynamic analysis of valnemulin against Mycoplasma gallisepticum S6 in Mycoplasma gallisepticum and Escherichia coli co-infected chickens.
    Xiao X; Sun J; Chen Y; Zou M; Zhao DH; Liu YH
    Vet J; 2015 Apr; 204(1):54-9. PubMed ID: 25744809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic and pharmacodynamic modeling of sarafloxacin against avian pathogenic Escherichia coli in Muscovy ducks.
    Yu Y; Zhou YF; Sun J; Shi W; Liao XP; Liu YH
    BMC Vet Res; 2017 Feb; 13(1):47. PubMed ID: 28183350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of faecal and optimal growth conditions on in vitro pharmacodynamic activity of marbofloxacin against Escherichia coli.
    Pellet T; Gicquel-Bruneau M; Sanders P; Laurentie M
    Res Vet Sci; 2006 Jun; 80(3):324-35. PubMed ID: 16126240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo pharmacokinetic/Pharmacodynamic modeling of Enrofloxacin against Escherichia coli in broiler chickens.
    Xiao X; Jiang L; Lan W; Jiang Y; Wang Z
    BMC Vet Res; 2018 Nov; 14(1):374. PubMed ID: 30497453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic and pharmacodynamic testing of marbofloxacin administered as a single injection for the treatment of bovine respiratory disease.
    Vallé M; Schneider M; Galland D; Giboin H; Woehrlé F
    J Vet Pharmacol Ther; 2012 Dec; 35(6):519-28. PubMed ID: 22126438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical pharmacokinetics and pharmacodynamic target attainment of pazufloxacin in prostate tissue: Dosing considerations for prostatitis.
    Nakamura K; Ikawa K; Nishikawa G; Kobayashi I; Narushima M; Muramatsu H; Morinaga S; Kajikawa K; Kato Y; Watanabe M; Zennami K; Kanao K; Morikawa N; Sumitomo M
    J Infect Chemother; 2017 Dec; 23(12):809-813. PubMed ID: 28923301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical pharmacokinetics/pharmacodynamics study on pazufloxacin methanesulphonate injection].
    Wang XG; Miao J; Liang DR; Yu Q; Liang MZ; Zhang SH
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Jul; 40(4):689-93. PubMed ID: 19764574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical efficacy of florfenicol administered in the drinking water against Ornithobacterium rhinotracheale in turkeys housed in different environmental conditions: a pharmacokinetic/pharmacodynamic approach.
    Watteyn A; Russo E; Garmyn A; De Baere S; Pasmans F; Martel A; Haesebrouck F; Montesissa C; De Backer P; Croubels S
    Avian Pathol; 2013; 42(5):474-81. PubMed ID: 23930788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic-pharmacodynamic integration of marbofloxacin after single and repeated intravenous administration in goats.
    Bhardwaj P; Sidhu PK; Lonare MK; Kaur R; Dumka VK; Rampal S
    Res Vet Sci; 2018 Dec; 121():111-115. PubMed ID: 30384141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.